Logo image of IRMD

IRADIMED CORP (IRMD) Stock Price, Quote, News and Overview

NASDAQ:IRMD - Nasdaq - US46266A1097 - Common Stock - Currency: USD

62.67  +1.44 (+2.35%)

After market: 62.67 0 (0%)

IRMD Quote, Performance and Key Statistics

IRADIMED CORP

NASDAQ:IRMD (2/5/2025, 8:07:39 PM)

After market: 62.67 0 (0%)

62.67

+1.44 (+2.35%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High63.29
52 Week Low40.18
Market Cap794.03M
Shares12.67M
Float7.98M
Yearly Dividend1.05
Dividend Yield0.99%
PE39.17
Fwd PE35.11
Earnings (Next)02-13 2025-02-13/amc
IPO07-16 2014-07-16


IRMD short term performance overview.The bars show the price performance of IRMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

IRMD long term performance overview.The bars show the price performance of IRMD in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of IRMD is 62.67 USD. In the past month the price increased by 10.94%. In the past year, price increased by 44.6%.

IRADIMED CORP / IRMD Daily stock chart

IRMD Latest News, Press Releases and Analysis

News Image
16 days ago - Chartmill

Reasonable Growth, Debt Levels, and a High ROIC Make IRADIMED CORP (NASDAQ:IRMD) Appealing to Quality Investors.

Why the quality investor may take a look at IRADIMED CORP (NASDAQ:IRMD).

News Image
7 days ago - iRadimed Corporation

IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth...

News Image
a month ago - iRadimed Corporation

IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues

Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 millionReports preliminary full-year 2024 revenue in...

IRMD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.28 229.05B
ISRG INTUITIVE SURGICAL INC 80.61 210.47B
BSX BOSTON SCIENTIFIC CORP 44.48 154.71B
SYK STRYKER CORP 32.74 152.14B
MDT MEDTRONIC PLC 17.46 117.57B
BDX BECTON DICKINSON AND CO 18.62 71.07B
EW EDWARDS LIFESCIENCES CORP 27 42.52B
GEHC GE HEALTHCARE TECHNOLOGY 20.66 39.83B
IDXX IDEXX LABORATORIES INC 41.65 38.36B
RMD RESMED INC 27.44 35.61B
DXCM DEXCOM INC 52.22 34.68B
PHG KONINKLIJKE PHILIPS NVR- NY 20.62 25.78B

About IRMD

Company Profile

IRMD logo image IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 148 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.

Company Info

IRADIMED CORP

1025 Willa Springs Dr.

Winter Springs FLORIDA 32708 US

CEO: Roger Susi

Employees: 148

Company Website: http://www.iradimed.com/

Investor Relations: https://www.iradimed.com/investors/events

Phone: 14076778022

IRMD FAQ

What is the stock price of IRMD?

The current stock price of IRMD is 62.67 USD.


What is the symbol for IRADIMED CORP stock?

The exchange symbol of IRADIMED CORP is IRMD and it is listed on the Nasdaq exchange.


On which exchange is IRMD stock listed?

IRMD stock is listed on the Nasdaq exchange.


Is IRMD a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for IRMD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of IRMD.


Does IRMD stock pay dividends?

IRMD has a dividend yield of 0.99%. The yearly dividend amount is currently 1.05.


When does IRMD stock report earnings?

IRMD will report earnings on 2025-02-13, after the market close.


What is the Price/Earnings (PE) ratio of IRMD?

The PE ratio for IRMD is 39.17. This is based on the reported non-GAAP earnings per share of 1.6 and the current share price of 62.67 USD.


What is the Short Interest ratio of IRMD stock?

The outstanding short interest for IRMD is 1.86% of its float.


IRMD Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to IRMD. When comparing the yearly performance of all stocks, IRMD is one of the better performing stocks in the market, outperforming 87.53% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IRMD Fundamental Analysis

ChartMill assigns a fundamental rating of 8 / 10 to IRMD. Both the health and profitability get an excellent rating, making IRMD a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IRMD Financial Highlights

Over the last trailing twelve months IRMD reported a non-GAAP Earnings per Share(EPS) of 1.6. The EPS increased by 13.48% compared to the year before.


Industry RankSector Rank
PM (TTM) 26.12%
ROA 19.76%
ROE 22.33%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%0%
Sales Q2Q%11.03%
EPS 1Y (TTM)13.48%
Revenue 1Y (TTM)13.24%

IRMD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to IRMD. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 14.41% and a revenue growth 11.59% for IRMD


Ownership
Inst Owners56.06%
Ins Owners37.01%
Short Float %1.86%
Short Ratio3.68
Analysts
Analysts82.5
Price Target66.3 (5.79%)
EPS Next Y14.41%
Revenue Next Year11.59%